Publication | Closed Access

Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells

NanomedicineDrug TargetingNanotherapeuticsHuman Colon CancerMedicineHt-29 CellsTherapeutic NanomaterialsPharmaceutical NanotechnologyDrug Delivery SystemsNano-drug DeliveryTumor TargetingPharmacologyRadiation OncologyCancer Research